Lucid Diagnostics (LUCD) Acquisitions (2022)
Lucid Diagnostics' (LUCD) quarterly Acquisitions came in at $1.0 million in Q3 2022.
Lucid Diagnostics (LUCD) Acquisitions (2022) Analysis & Trends
Lucid Diagnostics (LUCD) has 1 years of Acquisitions data on file, last reported at $1.0 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Lucid Diagnostics | 176.35 Mn | 142.94 Mn | 55,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.00 Mn |